Could Psychedelics Help Treat Alzheimer’s?
By Lecia Bushak | March 17th, 2020
More researchers are paying attention to the therapeutic benefits of psychedelics when it comes to treating mental illnesses like depression and addiction — and…
First Patient Receives Biogen’s Alzheimer’s Drug, Aducanumab, in New Trial
By Phil Gutis | March 13th, 2020
Being Patient Senior Reporter Phil Gutis spent the day with our patient advisor, Jeff Borghoff, who was the first recipient in Biogen’s latest trial…
A ‘Medical Emergency’: Experts Project Alzheimer’s Cases Will Triple by 2050
By Phil Gutis | March 12th, 2020
Barring any medical breakthroughs, the Alzheimer’s Association is warning that the number of cases of people living with Alzheimer’s may nearly triple by 2050….
Boosting the Brain’s Metabolism to Fight Alzheimer’s
By Lecia Bushak | March 11th, 2020
The factors that contribute to the development of Alzheimer’s disease are complex and varied. Scientists know that the buildup of tau and amyloid proteins…
Harnessing the Brain’s Immune Cells to Remove Amyloid Plaques in Alzheimer’s
By Phil Gutis | March 10th, 2020
Researchers in Germany and San Francisco believe they have identified an antibody that binds to the brain’s immune cells and causes them to live…
Could a Low-Carb Diet Reverse Aging in the Brain?
By Lecia Bushak | March 9th, 2020
Plenty of attention has been paid to the ketogenic diet in recent years—its supporters have touted its potential health benefits when it comes to…
Arthena Caston: ‘Living Joyfully’ with Alzheimer’s as an African American
By
Tanner Jensen
| March 6th, 2020
Rates of Alzheimer’s disease are around 14 percent higher among African Americans, and the symptoms are often dismissed or misdiagnosed. Being Patient spoke with…
Follow us